Cell and Gene Supply Chain Services Market to Grow with a CAGR of 9.64% through 2029

Growing investment in biotechnology are expected to drive the Global Cell and Gene Supply Chain Services Market growth in the forecast period, 2025-2029

 

According to TechSci Research report, “Cell and Gene Supply Chain Services Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, the Global Cell and Gene Supply Chain Services Market stood at USD 1.32 billion in 2023 and is anticipated to grow with a CAGR of 9.64% through 2029. The rising prevalence of chronic diseases like cancer and cardiovascular conditions, alongside the emergence of personalized medicine, is spurring demand for advanced treatments such as cell and gene therapies. Traditional approaches often fall short, prompting a shift toward innovative solutions. Consequently, there's a growing need for specialized logistics to deliver these treatments globally.

Increased investment in biotechnology research and development is a major driver of growth in the cell and gene supply chain services market. Pharmaceutical firms, biotech startups, and research centers are allocating significant resources to develop new therapies. This surge in biotech innovation underscores the importance of robust supply chain infrastructure for manufacturing, storage, and distribution.

Technological advancements are crucial for enhancing efficiency and scalability in the cell and gene supply chain services market. From temperature-controlled logistics to blockchain-based traceability, innovative technologies are reshaping how therapies are handled. Automation, AI, and data analytics are also optimizing supply chain processes and improving visibility and transparency.

The demand for cell and gene therapies is on the rise, revolutionizing disease treatment methods. These therapies involve using living cells or genetic materials to repair or alter damaged tissues. With an increasing number of approved therapies and a robust pipeline, there's a growing need for efficient and scalable supply chain services to meet demand.

The unique nature of cell and gene therapies presents challenges in the supply chain, necessitating tailored solutions. This trend favors customized supply chain services designed to meet the specific needs of each therapy. It includes specialized logistics, storage, and handling to preserve the integrity and viability of these products. Customized services ensure the safe and timely delivery of therapies, supporting their commercial success and widespread adoption. 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Cell and Gene Supply Chain Services Market”

The Global Cell and Gene Supply Chain Services Market is segmented into technology, applications, end user, regional distribution, and company

Based on the application, logistics segment emerged as the dominant segment in the global cell and gene supply chain services market in 2023. In the realm of cell and gene therapies, logistics is tasked with preserving the potency and integrity of these sensitive biological products. Unlike conventional pharmaceuticals, these therapies often demand precise temperature control, sometimes requiring cryogenic storage. The logistics segment ensures adherence to these stringent temperature requirements throughout the supply chain, employing specialized packaging, monitoring systems, and transportation vehicles to prevent deviations and maintain product stability. Regulatory compliance is paramount in the transportation and distribution of cell and gene therapies, with logistics navigating complex regulatory frameworks such as Good Distribution Practices (GDP) and Good Manufacturing Practices (GMP). Compliance with these regulations is indispensable for securing market authorization and facilitating the commercialization of these innovative therapies.

North America benefits from a robust regulatory framework that facilitates the development, approval, and commercialization of cell and gene therapies. Regulatory agencies like the Food and Drug Administration (FDA) in the United States provide clear guidelines and pathways for the approval of these advanced therapies, instilling confidence in companies to invest in research, development, and manufacturing. This regulatory clarity has contributed to North America's prominence in the global cell and gene supply chain services market. Moreover, North America leads in biotechnology innovation and investment, boasting a vibrant ecosystem of biopharmaceutical companies, research institutions, and academic centers.

 

Major companies operating in Global Cell and Gene Supply Chain Services Market are:

• Biocair International Limited
• Arvato SE
• Associated Couriers, LLC.
• TrakCel Limited
• Parkoursc Inc.
• DHL
• McKesson Corporation
• Almac Group Limited
• Catalent Inc.
• Biostor Ltd.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The Global Cell and Gene Supply Chain Services Market is poised for significant growth in the coming years. Anticipated advancements in cell and gene therapies, coupled with increasing prevalence of chronic diseases, are expected to fuel demand for specialized supply chain services. Moreover, growing investment in biotechnology, strategic partnerships, and technological innovations such as cloud-based solutions and blockchain traceability platforms are enhancing the efficiency, scalability, and reliability of supply chain operations. Regulatory support and frameworks further bolster the market by providing clarity and facilitating the development and commercialization of advanced therapies”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Cell and Gene Supply Chain Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Presence on cloud, Presence on-premises), By Applications (Ordering and scheduling, Sample collection, Logistics, Post treatment follow-up), By End User (Biobank/ cell-bank, Hospitals, Research institutes, Cell therapy labs, Others) Region and Competition, 2019-2029F”, has evaluated the future growth potential of Global Cell and Gene Supply Chain Services Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Cell and Gene Supply Chain Services Market.

 

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com